Revelation Biosciences News - REVB

Company Name	Stock Ticker Symbol	Market	Type
Revelation Biosciences Inc	REVB	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.1001	4.68%	2.24	12:38:50

Open Price	Low Price	High Price	Close Price	Prev Close
2.13	2.13	2.31		2.1399

more quote information »

Recent News

Date	Time	Source	Heading
3/22/2024	16:15	BW	Revelation Biosciences, Inc. Announces Financial Results for..
3/13/2024	09:00	BW	Revelation Biosciences Inc. Gives Oral Presentation at..
3/12/2024	09:00	BW	Revelation Biosciences Inc. to Participate in a Virtual..
3/04/2024	09:00	BW	Revelation Biosciences Inc. Announces Commencement of First..
2/13/2024	20:12	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	09:00	BW	Revelation Biosciences Inc. Receives Invitation to Give an..
2/12/2024	10:19	EDGAR2	Form SCHEDULE 13G/A - Statement of acquisition of beneficial..
2/08/2024	16:01	EDGAR2	Form 8-K - Current report
2/05/2024	16:41	BW	Revelation Biosciences Inc. Announces Closing of $6.2..
2/02/2024	16:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/01/2024	06:00	BW	Revelation Biosciences Inc. Announces Pricing of $6.2..
1/30/2024	17:21	EDGAR2	Form 8-K - Current report
1/30/2024	15:32	EDGAR2	Form S-1/A - General form for registration of securities..
1/30/2024	09:00	BW	Revelation Biosciences Inc. to Present at The International..
1/29/2024	17:32	EDGAR2	Form S-1/A - General form for registration of securities..
1/23/2024	16:18	EDGAR2	Form 8-K - Current report
1/23/2024	09:00	BW	Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock..
1/22/2024	16:01	EDGAR2	Form 8-K - Current report
12/22/2023	17:06	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/22/2023	13:23	EDGAR2	Form S-1 - General form for registration of securities under..
12/12/2023	16:59	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/13/2023	16:30	EDGAR2	Form 8-K - Current report
11/13/2023	16:05	BW	Revelation Biosciences, Inc. Announces Financial Results for..
11/09/2023	16:07	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/12/2023	16:26	EDGAR2	Form 8-K - Current report
10/12/2023	09:00	BW	Gemini Induces Pharmacologic Activity and Related..
10/04/2023	09:00	BW	Revelation Biosciences, Inc. to Present at the 2023 ROTH..
10/02/2023	16:24	EDGAR2	Form 8-K - Current report
10/02/2023	09:00	BW	Revelation Biosciences Inc. Announces Appointment of Lakhmir..
8/11/2023	16:30	EDGAR2	Form 8-K - Current report
8/11/2023	16:25	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/11/2023	16:10	BW	Revelation Biosciences Inc. Announces Financial Results for..
8/11/2023	16:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/2023	16:05	EDGAR2	Form 8-K - Current report
7/14/2023	16:51	EDGAR2	Form 8-K - Current report
7/07/2023	16:09	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
7/07/2023	16:07	EDGAR2	Form 8-K - Current report
6/29/2023	16:23	EDGAR2	Form 8-K - Current report
6/29/2023	09:00	BW	REMINDER: Revelation Biosciences, Inc. Urges All..
6/12/2023	16:15	BW	Revelation Biosciences Inc. Announces Adjournment of 2023..
5/22/2023	09:00	BW	Revelation Biosciences Inc. Announces Financial Results for..